BioAdvance
Venture Capital FirmPhiladelphia, PA 19087
United States
- Phone
- 610-230-0544
- info@bioadvance.com
- Website
- www.bioadvance.com (opens in a new tab)
- Contact
- Shahram Hejazi, Managing Director and CEO
- Type of firm
- Venture Capital Firm
- Minimum investment
- $250,000
- Maximum investment
- $1.25 million
- Stage preferences
- Seed stage
- Geographic preferences
- Southeastern Pennsylvania (Philadelphia, Bucks, Montgomery, Chester and Delaware Counties)
- Industry preferences
- Therapeutics, Medical Devices, Research Tools, Diagnostics, Health IT
BioAdvance is an evergreen fund established to address the shortage of seed and pre-seed capital for companies developing new technologies to improve human health.
Disclaimer: vcaonline.com does not take a commission on sales, and we cannot guarantee the services these firms provide or how quickly they respond. This service is provided as is. Its purpose is to save you time by letting you reach firms directly, so the people who can judge whether there is a match receive your enquiry.
VCPro Database 2026
$119.95
One-time purchaseResearching one firm at a time? See every firm, and who to call, in one place. Structured intelligence for active investment decision-makers.
- 7,670+ VC & PE firm profiles with direct executive contacts
- Built-in search filters & export capabilities
- Runs offline on Windows and macOS
- Includes free annual update (Jan 2027)